Clinical Trial

PRGF-ENDORET® Infiltrations in the Treatment of Low Back Pain.

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 6, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to evaluate the efficacy of PRGF in reducing pain and improving patients' quality of life. Researchers will compare an experimental drug (Plasma Rich in Growth Factors) to a control corticosteroid solution in saline solution.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-28.
Status change: Not Yet Recruiting → Recruiting 2025-02-04
Trial Details
NCT Number NCT06715085
Lead Sponsor Biotechnology Institute IMASD
Conditions Diseases [C] - Musculoskeletal Diseases [C05
Enrollment 48 participants
Start Date 2025-01-23
Primary Completion 2026-02-01 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-02-06